Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting

(2018) Elizabeth R. Seaquist et al.   DIABETES OBESITY & METABOLISM

A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setti

(2018) Larry C Deeb et al.   PEDIATRIC DIABETES

Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study

(2016) G. Veronese et al.   ACTA DIABETOLOGICA

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

(2016) Jennifer L. Sherr et al.   DIABETES CARE

Costs associated with emergency care and hospitalization for severe hypoglycemia

(2016) G. Veronese et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Needle-free nasal delivery of glucagon for treatment of diabetes-related severe hypoglycemia: toxicology of polypropylene resin used in delivery device

(2015) Frederick E. Reno et al.   Cutaneous and Ocular Toxicology

Identifying the worries and concerns about hypoglycemia in adults with type 2 diabetes

(2015) W.H. Polonsky et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

A novel nasal powder formulation of glucagon: toxicology studies in animal models

(2015) Frederick E. Reno et al.   BMC Pharmacology & Toxicology

Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations

(2014) Augusto Boido et al.   ACTA DIABETOLOGICA

Central Insulin Administration Improves Whole-Body Insulin Sensitivity via Hypothalamus and Parasympathetic Outputs in Men

(2014) M. Heni et al.   DIABETES

Are children with type 1 diabetes safe at school? Examining parent perceptions

(2014) Kimberly A Driscoll et al.   PEDIATRIC DIABETES

National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations

(2014) Andrew I. Geller et al.   JAMA Internal Medicine

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) E. R. Seaquist et al.   DIABETES CARE

The T1D Exchange Clinic Registry

(2012) Roy W. Beck et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes

(2011) S. Fourlanos et al.   DIABETES

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to

(2011) N. Mauras et al.   DIABETES CARE

Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis

(2011) A. E. Pontiroli et al.   DIABETES OBESITY & METABOLISM

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes

(2011) Eva Tsalikian et al.   PEDIATRIC DIABETES

CNS leptin and insulin action in the control of energy homeostasis

(2010) Bengt F. Belgardt et al.   Annals of the New York Academy of Sciences